Group 1 - The total salary scale of CFOs in A-share listed companies reached 4.27 billion yuan in 2024 [1] - Among the 38 listed medical device companies, the average annual salary of CFOs is 908,600 yuan [1] - The age distribution of CFOs shows that those aged 40-50 constitute 57%, while those over 50 account for 32% [1] Group 2 - The educational background of CFOs indicates that 66% hold a bachelor's degree, while only 2% have a doctoral degree [1] - The top three highest-paid CFOs in the medical device sector are Dai Zhenhua from Huatai Medical, Rui Chen from Nanwei Medical, and Wu Jinhong from Guoke Hengtai, with salaries of 2.70 million yuan, 2.65 million yuan, and 1.77 million yuan respectively [1] - The largest salary decrease was observed for Kong Xiangqian from Aidi Te, with a year-on-year decline of 16.86%, while Song Yizhao from Shandong Pharmaceutical Glass saw the largest increase at 144.86% [1]

Core Insights - The report highlights the significant role of CFOs in listed companies, with the total salary scale for CFOs in A-share companies reaching 4.27 billion yuan in 2024 [1] - The average annual salary for CFOs in the medical consumables sector is 908,600 yuan [1] Group 1: CFO Demographics - CFOs aged between 40 and 50 years constitute 57% of the market, while those over 50 years account for 32%, and those under 40 years make up 11% [1] - The youngest CFO currently in office is 33 years old [1] Group 2: Educational Background - The educational distribution of CFOs shows that 16% have an associate degree, 66% hold a bachelor's degree, 16% possess a master's degree, and only 2% have a doctoral degree [1] - Only one CFO, Huang Tiezhu from Aomei Medical, holds a doctoral degree [1] Group 3: Salary Distribution - The salary distribution among CFOs in the medical consumables sector is as follows: 24% earn below 500,000 yuan, 42% earn between 500,000 and 1 million yuan, 29% earn between 1 million and 2 million yuan, and 5% earn above 2 million yuan [1] - The top three highest-paid CFOs are Dai Zhenhua from Huitai Medical (2.70 million yuan), Rui Chen from Nanwei Medical (2.65 million yuan), and Wu Jinhong from Guoke Hengtai (1.77 million yuan) [1] Group 4: Salary Changes - Among CFOs with over two years of tenure, the largest salary decrease was observed for Kong Xiangqian from Aideite, with a year-on-year decline of 16.86% [1] - The largest salary increase was recorded for Song Yizhao from Shandong Yaobo, with a year-on-year increase of 144.86% [1]

Group 1: 惠泉啤酒 - Company achieved a net profit of 39.57 million yuan in the first half of 2025, representing a year-on-year increase of 25.52% [1] - Revenue for the same period was 351 million yuan, showing a growth of 1.03% year-on-year [1] - Company specializes in the production and sale of beer, established in February 1997 [1] Group 2: 格尔软件 - Company plans to raise no more than 283 million yuan through a simplified procedure for issuing A-shares [1] - The funds will be used for quantum password technology industrialization, trusted data space platform development, and to supplement working capital [1] - Established in March 1998, the company focuses on digital trust and data security products [1] Group 3: 银轮股份 - Certain directors and executives plan to reduce their holdings by up to 964,000 shares, accounting for 0.1158% of the total share capital [1] - The reduction is due to personal funding needs [1] - Company specializes in heat exchange products and automotive air conditioning, established in March 1999 [2] Group 4: 共创草坪 - Controlling shareholder's related parties plan to reduce their holdings by up to 0.8% of the company's shares [3] - The reduction will occur through centralized bidding and block trading [3] - Company focuses on the research, production, and sale of artificial turf, established in January 2004 [3] Group 5: ST纳川 - Senior management plans to reduce their holdings by up to 27,200 shares, representing 0.0026% of the total share capital [4] - The reduction is due to personal funding needs [4] - Company specializes in the research, manufacturing, and sales of water supply and drainage pipes, established in June 2003 [4] Group 6: 东芯股份 - Company clarified that its investment in Shanghai Lisan's chip products is not intended for large model computing clusters [6] - The products are mainly for personal computers, professional design, cloud gaming, and other applications [6] - Established in November 2014, the company focuses on independent research, design, and sales of small-capacity storage chips [6] Group 7: 南卫股份 - Company and its controlling shareholder received an administrative penalty notice from Jiangsu Securities Regulatory Bureau for insider trading [6] - The financial director and the controlling shareholder face fines and confiscation of illegal gains [6] - Established in July 1990, the company specializes in medical adhesive products and protective supplies [7] Group 8: 兰花科创 - Company plans to acquire 62% of Shandong Jiaxiang Yilong Port Co., Ltd. for 149 million yuan [8] - This acquisition aims to enhance the company's presence in inland shipping and logistics [8] - Established in December 1998, the company focuses on the production and sale of coal, fertilizers, and building materials [9] Group 9: 伟隆股份 - Controlling shareholder's related party plans to reduce holdings by up to 1.89 million shares, accounting for 0.7664% of the total share capital [10] - The reduction will occur through centralized bidding or block trading [10] - Established in June 1995, the company specializes in the production and sales of valves and related components [10] Group 10: 埃夫特 - Company's subsidiary received a government subsidy of 50 million yuan for a project related to intelligent robots [11] - The subsidy is pending receipt [11] - Established in August 2007, the company focuses on the research, production, and sales of industrial robots [11] Group 11: 华测导航 - Company reported a net profit of 32.6 million yuan in the first half of 2025, a year-on-year increase of 29.94% [13] - Revenue for the same period was 1.833 billion yuan, reflecting a growth of 23.54% year-on-year [13] - Established in September 2003, the company specializes in high-precision navigation and positioning technologies [13] Group 12: 德生科技 - Company directors plan to reduce their holdings by up to 0.025% of the total share capital [14] - The reduction is due to personal funding needs [14] - Established in August 1999, the company focuses on the production and sales of social security cards and related services [15] Group 13: 百邦科技 - Company director plans to reduce holdings by up to 0.19% of the total share capital [16] - The reduction is due to personal funding needs [16] - Established in November 2007, the company specializes in mobile phone after-sales services [17] Group 14: 中集车辆 - Shareholders plan to reduce holdings by up to 0.69% of the total share capital [18] - The reduction will occur through centralized bidding and block trading [18] - Established in August 1996, the company focuses on the production and sales of semi-trailers and specialized vehicles [18] Group 15: 新时达 - Company’s application for a private placement was accepted by the Shenzhen Stock Exchange [19] - The application is subject to further review and approval by the regulatory authorities [19] - Established in March 1995, the company specializes in intelligent manufacturing and industrial robotics [19] Group 16: 隆扬电子 - Company plans to reduce up to 592,400 repurchased shares, accounting for 0.21% of the total share capital [20] - The reduction will occur through centralized bidding [20] - Established in March 2000, the company focuses on the research, production, and sales of electromagnetic shielding materials [20] Group 17: 华熙生物 - Controlling shareholder plans to increase holdings by 200 to 300 million yuan [21] - The increase will occur within six months at a price not exceeding 70 yuan per share [21] - Established in January 2000, the company specializes in the research, production, and sales of hyaluronic acid and related medical materials [21] Group 18: 天域生物 - Company reported sales revenue of 21.03 million yuan from pig sales in July, a year-on-year decrease of 37.23% [22] - Cumulative sales from January to July reached 333 million yuan, a year-on-year increase of 11.35% [22] - Established in June 2000, the company focuses on ecological agriculture and livestock farming [22] Group 19: 城地香江 - Subsidiary signed a significant data center hosting contract with an internet company, with an estimated first phase contract value of up to 1.811 billion yuan [23] - The second phase is expected to be valued at up to 2.716 billion yuan, with details yet to be specified [23] - Established in April 1997, the company specializes in IDC investment and operations [23]

专题：专题|2024年度A股CFO数据报告：美的集团钟铮年薪946万，比亚迪周亚琳896万 作为上市公司核心管理层关键成员，财务总监CFO的地位与作用至关重要。新浪财经《2024年度A股 CFO数据报告》显示，2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元，平均年薪为 81.48万元。 从CFO的学历分布看，拥有大专、本科、硕士、博士学历的CFO占比分别为16%、66%、16%、2%。其 中，获得博士学历的CFO仅一人，为奥美医疗的黄铁柱。 从薪酬分布看，A股医疗耗材公司CFO年薪平均值为90.86万元。经统计，处于50万以下、50万-100万、 100万-200万、200万以上各区间的人数占比分别为24%、42%、29%、5%。 其中，年薪排行前三的CFO分别为惠泰医疗的戴振华、南微医学的芮晨为、国科恒泰的吴锦洪，三人年 薪分别为270.18万元、265.25万元、176.56万元。 从薪酬变动幅度看（仅统计任职两年以上CFO薪资数据），爱迪特的孔祥乾2024年薪酬降幅最大，同比 降幅达16.86%；山东药玻的宋以钊薪酬增幅最大，同比涨幅达144.86%。 责任编辑：公司观察 分行业来 ...

Core Insights - The report highlights the significant role of CFOs in listed companies, with the total compensation for A-share CFOs reaching 4.27 billion yuan in 2024, averaging 814,800 yuan per year [1][2] Group 1: CFO Compensation Overview - The average annual salary for CFOs in the A-share medical device sector is 908,600 yuan [2] - The distribution of CFO salaries shows that 24% earn below 500,000 yuan, 42% earn between 500,000 and 1 million yuan, 29% earn between 1 million and 2 million yuan, and 5% earn above 2 million yuan [2] - The top three highest-paid CFOs are Dai Zhenhua from Huatai Medical at 2.70 million yuan, Rui Chenwei from Nanwei Medical at 2.65 million yuan, and Wu Jinhong from Guoke Hengtai at 1.77 million yuan [2] Group 2: CFO Demographics - The age distribution of CFOs shows that those aged 40-50 make up 57%, while 32% are over 50, and 11% are 40 or younger [1] - The youngest CFO is 31 years old, while the oldest is 60 years old [1] - In terms of educational background, 16% of CFOs have an associate degree, 66% hold a bachelor's degree, 16% have a master's degree, and only 2% possess a doctoral degree [1] Group 3: Salary Changes - Among CFOs with over two years of tenure, the largest salary decrease was observed for Kong Xiangqian from Aidi Te, with a decline of 16.86% year-on-year [2] - Conversely, the largest salary increase was for Song Yizhao from Shandong Glass, with a rise of 144.86% year-on-year [2]

Core Insights - The report highlights the significant role and compensation of CFOs in A-share listed companies, with a total salary scale of 4.27 billion yuan and an average annual salary of 814,800 yuan for CFOs in 2024 [1][2] Group 1: CFO Compensation Overview - The average annual salary for CFOs in the medical device sector of A-shares is 908,600 yuan [2] - The distribution of CFO salaries shows that 24% earn below 500,000 yuan, 42% earn between 500,000 and 1 million yuan, 29% earn between 1 million and 2 million yuan, and 5% earn above 2 million yuan [2] - The top three highest-paid CFOs are Dai Zhenhua from Huatai Medical at 2.70 million yuan, Rui Chenwei from Nanwei Medical at 2.65 million yuan, and Wu Jinhong from Guoke Hengtai at 1.77 million yuan [2] Group 2: CFO Demographics - The age distribution of CFOs indicates that those aged 40-50 constitute 57%, while 32% are over 50, and 11% are 40 or younger [1] - The youngest CFO is 31 years old, Shao Kejie from Tianyi Medical, while the oldest is 60 years old, Xiang Qinhua from Nanwei Co., Ltd. [1] - In terms of educational background, 16% of CFOs have an associate degree, 66% hold a bachelor's degree, 16% have a master's degree, and only 2% possess a doctoral degree, with only one CFO holding a PhD [1]

Core Insights - The report highlights the significant role of CFOs in listed companies, with the total salary scale for A-share CFOs reaching 4.27 billion yuan in 2024, averaging 814,800 yuan per year [1][2] Salary Distribution - The average annual salary for CFOs in the A-share medical device sector is 908,600 yuan, with 24% earning below 500,000 yuan, 42% between 500,000 and 1 million yuan, 29% between 1 million and 2 million yuan, and 5% earning above 2 million yuan [2] - The top three highest-paid CFOs are Dai Zhenhua from Huatai Medical at 2.70 million yuan, Rui Chenwei from Nanwei Medical at 2.65 million yuan, and Wu Jinhong from Guoke Hengtai at 1.77 million yuan [2] CFO Age Distribution - CFOs aged 40-50 constitute 57% of the market, while those over 50 account for 32%, and those 40 and below make up 11%. The youngest CFO is 31 years old, and the oldest is 60 years old [1] CFO Educational Background - The educational background of CFOs shows that 16% have an associate degree, 66% hold a bachelor's degree, 16% have a master's degree, and only 2% possess a doctoral degree, with only one CFO holding a PhD [1]

专题：专题|2024年度A股董秘数据报告：1144位董秘年薪超百万 占比超21% 从董秘的年龄分布来看，40岁-50岁董秘是市场的中坚力量，占比共计达到45%；50岁以上的董秘占比为14%；30岁-40岁的董秘群体占比为36%；30岁及以下董秘群体占比为5%。其中，目前仍 从董秘的学历分布看，拥有专科、本科、硕士、博士学历的董秘占比分别为7%、45%、43%、5%。其中，获得博士学历的董秘共2人，分别为奥精医疗的仇志烨、中红医疗的张琳波。 从薪酬分布看，A股医疗耗材公司董秘年薪平均值为81.7万元。经统计，处于50万以下、50万-100万、100万-200万、200万以上各区间的人数占比分别为30%、41%、27%、2%。 其中，年薪排行前三的董秘分别为南微医学的龚星亮、微电生理的朱郁、威高骨科的林青，三人年薪分别为221.61万元、167.64万元、161.42万元。 从薪酬变动幅度看（仅统计任职两年以上董秘薪资数据），西山科技的白雪2024年薪酬降幅最大，同比降幅达54.09%；维力医疗的陈斌薪酬增幅最大，同比涨幅达191.72%。 责任编辑：公司观察 董秘作为连接投资者与上市公司的"桥梁"，在上市公司资 ...

专题：专题|2024年度A股董秘数据报告：1144位董秘年薪超百万 占比超21% 从薪酬分布看，A股医疗耗材公司董秘年薪平均值为81.7万元。经统计，处于50万以下、50万-100万、 100万-200万、200万以上各区间的人数占比分别为30%、41%、27%、2%。 董秘作为连接投资者与上市公司的"桥梁"，在上市公司资本运作中发挥着关键作用。新浪财经《2024年 度A股董秘数据报告》显示，2024年A股上市公司董秘薪酬合计达40.86亿元，平均年薪75.43万元。 分行业来看，统计数据显示，剔除董秘已离任公司后，A股共有44家上市医疗耗材公司，其聘任总体情 况如下（部分统计口径剔除无效数据）。 从董秘的年龄分布来看，40岁-50岁董秘是市场的中坚力量，占比共计达到45%；50岁以上的董秘占比 为14%；30岁-40岁的董秘群体占比为36%；30岁及以下董秘群体占比为5%。其中，目前仍任职的最年 轻的男上市公司董秘年龄30岁，为采纳股份的陆维炜；最年轻的女董秘年龄为29岁，为华兰股份的刘 雪。 从董秘的学历分布看，拥有专科、本科、硕士、博士学历的董秘占比分别为7%、45%、43%、5%。其 中，获得博士学历 ...

Core Insights - The report highlights that the total salary of A-share listed company secretaries in 2024 reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - A total of 1,144 company secretaries earned over 1 million yuan, accounting for more than 21% of the total [1] Salary Distribution - The average annual salary of company secretaries in the medical consumables sector is 817,000 yuan [2] - Salary distribution among company secretaries is as follows: below 500,000 yuan (30%), 500,000-1,000,000 yuan (41%), 1,000,000-2,000,000 yuan (27%), and above 2,000,000 yuan (2%) [2] - The top three highest-paid company secretaries are: Gong Xingliang from Nanwei Medical (2.2161 million yuan), Zhu Yu from Microelectrophysiology (1.6764 million yuan), and Lin Qing from Weigao Orthopedics (1.6142 million yuan) [2] Age and Education Distribution - The age distribution of company secretaries shows that those aged 40-50 constitute 45%, while those over 50 account for 14%, and those aged 30-40 make up 36% [1] - The educational background of company secretaries is as follows: 7% have an associate degree, 45% hold a bachelor's degree, 43% have a master's degree, and 5% possess a doctoral degree [1] Salary Changes - Among company secretaries with over two years of tenure, the largest salary decrease was observed for Bai Xue from Xishan Technology, with a year-on-year decline of 54.09% [2] - The highest salary increase was recorded for Chen Bin from Weili Medical, with a year-on-year increase of 191.72% [2]